Head-to-head · WeighScore
Enhance MD vs Sunlight.com
The verdict
Enhance MD takes it — 84.8/100 to 83.7/100, but only just.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side. Sunlight.com is close behind and may still be the better fit — see the factor split below.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Enhance MD | Sunlight.com |
|---|---|---|
| WeighScore | 84.8/100 | 83.7/100 |
| Grade | B | B |
| Site position | #5 | #22 |
| Semaglutide | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay | From $88/month advertised; confirm charge and term |
| Tirzepatide | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay | From $157/month advertised; confirm charge and term |
| Coverage | Not publicly listed | Nationwide platform; treatment availability varies by state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #5 · B
Strengths
- Transparent tiered pricing across sema, tirz, microdose, and combo
- Dose-flat — the price does not step up as you titrate
- Six-month lab testing plus provider-led care
- NAD+ longevity adjacency available
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- No oral or sublingual route
- States served are not published
- Higher entry price than the cheapest compounded programs
Site position #22 · B
Strengths
- Public FAQ advertises semaglutide from $88 and tirzepatide from $157 monthly
- Names six pharmacy partners and the Lion MD clinical network
- Medication if approved, telehealth visits and shipping are included
Where it loses points
- Exact payment and any prepaid commitment were not verified without completing intake
- Landing-page shipping claims differ from the FAQ’s within-seven-business-days statement
- Oral options appear in marketing but no specific oral GLP-1 offer was confirmed
- Refunds are unavailable once a prescription is written and sent to the pharmacy
Featured provider
Enhance MD
Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.